Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 29, 2026
TickeronGET DAILY SIGNALS
Exponent (EXPO) Reports Strong Third-Quarter Results and Raises Full-Year Outlook

Exponent (EXPO) Reports Strong Third-Quarter Results and Raises Full-Year Outlook

Key Takeaways

  • Total revenues climbed 18% year over year to $173.7 million, while net revenues (revenues before reimbursements) rose 12% to $153.1 million.
  • Diluted earnings per share (EPS) increased 16% to $0.64, topping consensus estimates of roughly $0.60 to $0.63.
  • Net income grew 10% to $30.9 million, and EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 16% to $45.0 million.
  • Consultant utilization improved to 76.7% from 74.1% a year earlier, and the realized billing rate increased about 4%.
  • Management raised full-year guidance, now expecting net revenues to grow 10% to 11% with an EBITDA margin of 28.0% to 28.3%.
  • The company declared a regular quarterly dividend of $0.31 per share, payable on December 18, 2026.

Earnings in Context

Exponent, Inc. (EXPO) operates as a science and engineering consulting firm focused on product failure analysis, litigation support, and user research. Its performance offers a window into corporate spending on specialized technical expertise amid uncertain economic conditions. After a strong second quarter, the third-quarter report showed whether that momentum could continue. The results delivered double-digit gains in revenues, earnings, and margins, underscoring resilient demand for the firm’s services. With artificial intelligence representing a larger portion of operations and management raising its outlook, the quarter provides clearer signals on both near-term execution and the sustainability of longer-term growth drivers. I also checked comparable names in the space using Tickeron’s AI Screener to put these trends in perspective.

Reported Results

For the third quarter of fiscal 2026 ended October 2, 2026, total revenues reached $173.7 million, up 18% from $147.1 million a year earlier. Net revenues, the measure management emphasizes, advanced 12% to $153.1 million from $137.1 million. The difference stems from higher reimbursable expenses that pass through total revenues without contributing to profitability.

Net income rose 10% to $30.9 million, and diluted EPS climbed 16% to $0.64 from $0.55. The figure exceeded consensus forecasts in the $0.60 to $0.63 range. EBITDA increased 16% to $45.0 million, yielding a margin of 29.4% of net revenues compared with 28.3% in the prior-year quarter.

Operating metrics remained solid. Billable hours grew 8% to roughly 405,000, utilization moved up to 76.7%, and average technical full-time equivalent headcount rose 4% to 1,016. The engineering and other scientific segment, accounting for 85% of net revenues, expanded 13%, while the environmental and health segment, representing 15%, grew 3%.

Market Reaction and Investor Sentiment

Coming into the quarter, expectations were already elevated after the second-quarter beat. The latest results again surpassed consensus on both revenue and earnings lines. EXPO has now topped EPS estimates for four straight quarters, which has helped sustain investor confidence. Management’s decision to raise full-year guidance added further support, suggesting the gains reflect more than just favorable project timing.

Commentary on artificial intelligence also drew attention. Management indicated AI is a direct component of roughly 15% to 20% of the business this year. Combined with higher utilization and an improved billing rate, the update framed the quarter as evidence of both demand strength and disciplined operations. I reviewed the AI-related commentary against broader sector data via Tickeron’s AI Trend Prediction Engine to confirm the positioning.

Forward Outlook and Key Factors to Monitor

Guidance was lifted for the balance of the fiscal year. For the fourth quarter, net revenues before reimbursements are expected to grow 8% to 10% year over year, with EBITDA projected at 26.3% to 26.8% of net revenues. For full fiscal 2026, management now forecasts net revenue growth of 10% to 11% and an EBITDA margin of 28.0% to 28.3%.

Several items warrant close attention going forward. Utilization and headcount trends will show whether the firm can scale while managing compensation pressures amid competition for engineering talent. The pace of user research and AI-related work will indicate whether the fastest-growing demand areas remain intact.

Capital allocation is another focus. Through the first three quarters, EXPO repurchased $146.1 million of stock and continues paying a quarterly dividend while holding $114.7 million in cash. How management balances returns to shareholders with investments in infrastructure and talent will influence profitability and growth. These factors, more than any single quarter’s numbers, are likely to shape the stock’s path ahead.

Enhancing Research with Tickeron Tools

When preparing this review, I turned to Tickeron’s AI Screener to compare EXPO with industry peers and surface similar opportunities. The tool provides a practical way to apply customizable filters across fundamentals, patterns, and performance metrics, helping refine the analysis efficiently.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: EXPO

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


EXPO in +2.27% Uptrend, advancing for three consecutive days on November 16, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EXPO advanced for three days, in 166 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 124 of 222 cases where EXPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for EXPO turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 32 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

EXPO broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. EXPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.841) is normal, around the industry mean (15.143). P/E Ratio (37.509) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (3.522). Dividend Yield (0.015) settles around the average of (0.215) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (2.886).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are MasTec (NYSE:MTZ).

Industry description

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

Market Cap

The average market capitalization across the Engineering & Construction Industry is 6.82B. The market cap for tickers in the group ranges from 69 to 2.15T. WKAPF holds the highest valuation in this group at 2.15T. The lowest valued company is WLGSF at 69.

High and low price notable news

The average weekly price growth across all stocks in the Engineering & Construction Industry was -9%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -32%. PMA experienced the highest price growth at 19%, while FGL experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Engineering & Construction Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 59% and the average quarterly volume growth was 46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 59
Price Growth Rating: 64
SMR Rating: 71
Profit Risk Rating: 78
Seasonality Score: -15 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a engineering and scientific consulting company

Industry EngineeringConstruction

Industry
Engineering And Construction
Address
149 Commonwealth Drive
Phone
+1 650 326-9400
Employees
1212
Web
https://www.exponent.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.
Exponent (EXPO) Reports Strong Third-Quarter Results and Raises Full-Year Outlook